| Financial Year |
March 31 2023 |
| Monetary Funds |
311,753,483.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
301,597,261.34 |
| Accounts Receivable |
78,916,641.65 |
| Advances to Suppliers |
52,645,125.03 |
| Other Receivables |
101,610.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
321,668,377.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,002,013.11 |
| Total Current Assets |
1,138,944,279.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
663,056,944.26 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,696,096.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,244,755.66 |
| Deferred Income Tax Assets |
15,527,284.02 |
| Other Non-Current Assets |
264,670,659.49 |
| Sub-Total of Non-Current Assets |
1,022,540,824.97 |
| Total Assets |
2,161,485,103.98 |
| Short-Term Loans |
114,954,041.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,216,900.00 |
| Accounts Payable |
219,228,480.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,292,677.25 |
| Taxes Payable |
3,820,857.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,711,278.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
270,238.80 |
| Other Current Liabilities |
216,870,657.69 |
| Sub-Total of Current Liabilities |
700,378,753.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
502,470,096.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
595,160,654.41 |
| Total Liabilities |
1,295,539,408.24 |
| Paid-In Capital(Or Share Stock) |
268,209,000.00 |
| Capital Surplus |
337,911,904.50 |
| Surplus Reserve |
36,570,182.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
223,254,608.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
865,945,695.74 |
| Owner's Equity（Stockholder's Equity） |
865,945,695.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,161,485,103.98 |
